201 related articles for article (PubMed ID: 3495523)
21. Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation.
Amatruda TT; Bohman R; Ranyard J; Koeffler HP
Blood; 1987 Apr; 69(4):1225-36. PubMed ID: 3103718
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
Pawelec G; Schneider EM; Müller C; Wernet P
Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
[TBL] [Abstract][Full Text] [Related]
24. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
25. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
26. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
27. [CD4+T cells restricted by DQ not by DR support CD8+T cells to grow].
Kamikawaji N
Fukuoka Igaku Zasshi; 1990 Feb; 81(2):88-96. PubMed ID: 2328939
[TBL] [Abstract][Full Text] [Related]
28. Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants.
Hanke JH; Cook RG; Lopez LA; Rich RR
J Immunol; 1987 Apr; 138(8):2384-91. PubMed ID: 3494064
[TBL] [Abstract][Full Text] [Related]
29. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
[TBL] [Abstract][Full Text] [Related]
30. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
31. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
32. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans.
Hirayama K; Matsushita S; Kikuchi I; Iuchi M; Ohta N; Sasazuki T
Nature; 1987 Jun 4-10; 327(6121):426-30. PubMed ID: 3108669
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
34. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
35. Immune response to Toxoplasma gondii--analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis.
Yano A; Norose K; Yamashita K; Aosai F; Sugane K; Segawa K; Hayashi S
J Parasitol; 1987 Oct; 73(5):954-61. PubMed ID: 2958613
[TBL] [Abstract][Full Text] [Related]
36. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction.
Gehrz RC; Fuad S; Liu YN; Bach FH
J Immunol; 1987 May; 138(10):3145-51. PubMed ID: 2437182
[TBL] [Abstract][Full Text] [Related]
37. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
39. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
40. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
